» Articles » PMID: 15494400

ATP Effects on Insulin-degrading Enzyme Are Mediated Primarily Through Its Triphosphate Moiety

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 Oct 21
PMID 15494400
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

It has been reported previously that ATP inhibits the insulysin reaction (Camberos, M. C., Perez, A. A., Udrisar, D. P., Wanderley, M. I., and Cresto, J. C. (2001) Exp. Biol. Med. 226, 334-341). We report here that with 2-aminobenzoyl-GGFLRKHGQ-ethylenediamine-2,4-dinitrophenyl as substrate, ATP and other nucleotides increase the rate >20-fold in Tris buffer. There is no specificity with respect to the nucleotide; however, ATP is more effective than ADP, which is more effective than AMP. Triphosphate itself was as effective as ATP, indicating it is this moiety that is responsible for activation. The binding of triphosphate was shown to be at a site distinct from the active site, thus acting as a noncompetitive activator. With the physiological substrates insulin and amyloid beta peptide, nucleotides and triphosphate were without effect. However, with small physiological peptides such as bradykinin and dynorphin B-9, ATP and triphosphate increased the rate of hydrolysis approximately 10-fold. Triphosphate and ATP shifted the oligomeric state of the enzyme from primarily dimer-tetramers to a monomer. These data suggest the presence of an allosteric regulatory site on insulysin that may shift its specificity toward small peptide substrates.

Citing Articles

The Insulin-Degrading Enzyme from Structure to Allosteric Modulation: New Perspectives for Drug Design.

Tundo G, Grasso G, Persico M, Tkachuk O, Bellia F, Bocedi A Biomolecules. 2023; 13(10).

PMID: 37892174 PMC: 10604886. DOI: 10.3390/biom13101492.


Exchange Broadening Underlies the Enhancement of IDE-Dependent Degradation of Insulin by Anionic Membranes.

Zheng Q, Lee B, Kebede M, Ivancic V, Kemeh M, Brito H ACS Omega. 2022; 7(28):24757-24765.

PMID: 35874268 PMC: 9301717. DOI: 10.1021/acsomega.2c02747.


Exploring the Structural Rearrangements of the Human Insulin-Degrading Enzyme through Molecular Dynamics Simulations.

Ghoula M, Janel N, Camproux A, Moroy G Int J Mol Sci. 2022; 23(3).

PMID: 35163673 PMC: 8836115. DOI: 10.3390/ijms23031746.


Alzheimer's Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound.

He Z, You G, Liu Q, Li N Int J Mol Sci. 2021; 22(21).

PMID: 34769364 PMC: 8584792. DOI: 10.3390/ijms222111931.


Dissecting the activation of insulin degrading enzyme by inositol pyrophosphates and their bisphosphonate analogs.

Hostachy S, Utesch T, Franke K, Dornan G, Furkert D, Turkaydin B Chem Sci. 2021; 12(32):10696-10702.

PMID: 34476054 PMC: 8372538. DOI: 10.1039/d1sc02975d.